PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 26, 2026British Journal of Dermatology0 citations

Comment on ‘Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden’: reply from authors

View Full Paper
MMMarko MarjanovicRMRasmus MikiverKNKári Rubek Nielsen

Key Points

  • The aim is to address comments and provide clarifications regarding survival outcomes and patient characteristics in melanoma.
  • Responding to critiques of the original study
  • Clarifying interpretation of data
  • Highlighting previously underappreciated findings
  • Affirming the robustness of survival outcome data
  • Highlighting key patient characteristics that affect survival
  • Reiterating the significance of population-based registry data

Abstract

Response to “Comment on ‘Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden’” by Qi at al from the authors of the original article.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Marjanovic et al. (2026) studied this question.

synapsesocial.com/papers/699fe44895ddcd3a253e8751https://doi.org/10.1093/bjd/ljag059
Ask AI
Helpful
Bookmark
Share
View Full Paper